Menu
GOVPH
Home
HTA Governance
Universal Health Care Act
Administrative Order on HTA
Philippine HTA Process Guide
Philippine HTA Methods Guide
Philippine HTA Code of Conduct
About Us
Mission/Vision
Health Technology Assessment Council (HTAC)
Health Technology Assessment Unit (HTAU)
HTA Philippines Annual Report
2019 HTA Annual Report
2020 HTA Annual Report
Road to HTA Institutionalization
External Partners
Assessments
Status of Assessments
Timeline of Assessments
Major Application
Expedited
COVID-19 Vaccines
Other COVID-19 Health Technologies
Urgent
General
Minor Application
Issuances
Evidence Briefs
FAQs
Get Involved with Us
Contact Us
Call for Nomination
Call for Interested Parties
Topic Nomination
AUXILIARY MENU
GOVPH
Home
HTA Governance
Universal Health Care Act
Administrative Order on HTA
Philippine HTA Process Guide
Philippine HTA Methods Guide
Philippine HTA Code of Conduct
About Us
Mission/Vision
Health Technology Assessment Council (HTAC)
Health Technology Assessment Unit (HTAU)
HTA Philippines Annual Report
2019 HTA Annual Report
2020 HTA Annual Report
Road to HTA Institutionalization
External Partners
Assessments
Status of Assessments
Timeline of Assessments
Major Application
Expedited
COVID-19 Vaccines
Other COVID-19 Health Technologies
Urgent
General
Minor Application
Issuances
Evidence Briefs
FAQs
Get Involved with Us
Contact Us
Call for Nomination
Call for Interested Parties
Topic Nomination
SARS-CoV-2 Vaccine (Vero Cell), Inactivated [CoronaVac] for the prevention of COVID-19
